Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Pharmacotherapy for MASLD/MASH: approved therapies, drug repurposing, and emerging mechanism-based candidates
Expert opinion on pharmacotherapy, 2026
Real-World Treatment Patterns and Weight Outcomes Before and After a Tirzepatide Price Increase in Over One Million Self-Paying UK Adults With Overweight or Obesity
Diabetes, obesity & metabolism, 2026
Emerging therapies for knee osteoarthritis
Nature reviews. Rheumatology, 2026
Detection of CJC-1295 in Equine Plasma by ELISA
Drug testing and analysis, 2026
Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review
Sexual medicine reviews;14(4)
Weight-Loss Outcomes After Sleeve Gastrectomy Versus Tirzepatide in a Minority Cohort With Severe Obesity: Results From a Propensity Score Matched Cohort
Clinical obesity;16(6):e70116
Short-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease
Medicine;105(41):e51019
Tirzepatide-induced pneumatosis intestinalis: a rare but clinically significant gastrointestinal adverse effect
American journal of clinical pathology;166(4)
Early Uptake of Oral Semaglutide for Obesity Treatment After Regulatory Approval
Annals of internal medicine, 2026
Effects of tirzepatide (GIP/GLP-1 dual receptor agonist) on cardiorenal biomarkers and functional capacity in heart failure: a systematic review and meta-analysis
The Journal of clinical endocrinology and metabolism, 2026
Endothelial AGGF1 contributes to glomerular barrier dysfunction via TNFSF12/FN14-Src-VE-cadherin signaling in diabetic kidney disease
Molecular and cellular endocrinology, 2026;:112931
Audiovestibular adverse event reporting profiles of GLP-1 receptor agonists: A case-case pharmacovigilance study using FDA AEMS data
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026
Body Weight Changes and Exploratory Metabolic Outcomes During Semaglutide and Tirzepatide Treatment: A Real-World Longitudinal Cohort Study from Türkiye
Journal of clinical medicine, 2026;15(20)
From pathophysiology to therapy: dual and triple agonists as a new frontier in metabolic dysfunction-associated steatotic liver disease
Frontiers in pharmacology, 2026;17:1784959
Characterizing the Adverse Event Profile of Semaglutide: A Comprehensive U.S. Food and Drug Administration Adverse Event Reporting System-Based Pharmacovigilance Study
Clinical nutrition ESPEN, 2026;:105169
GLP-1RA based treatment in patients with a PCSK1 mutation has profound effects on body weight – two case reports
Obesity facts, 2026;:1
Weight Maintenance Following Discontinuation of Semaglutide in an Adolescent with Antipsychotic-Associated Weight Gain: A Case Report
Hormone research in paediatrics, 2026;:1
Semaglutide in Heart Failure with Preserved Ejection Fraction and Obesity: The Gap Between Discussion and Use
Cardiology, 2026;:1
Tirzepatide use in adolescents with metabolic dysfunction-associated steatotic liver disease (MASLD): A case series
JPGN reports, 2026
The pharmacotherapy for pediatric obesity: insights and challenges from adult weight-loss medications
Journal of diabetes and metabolic disorders, 2026;25(2):289